Accucare Pediatric Nursing and Home Care Revenue and Competitors

Nanuet, NY

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • Accucare Pediatric Nursing and Home Care's estimated annual revenue is currently $12.6M per year.(i)
  • Accucare Pediatric Nursing and Home Care's estimated revenue per employee is $243,000

Employee Data

  • Accucare Pediatric Nursing and Home Care has 52 Employees.(i)
  • Accucare Pediatric Nursing and Home Care grew their employee count by 11% last year.

Accucare Pediatric Nursing and Home Care's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.1M330%N/AN/A
#2
$21.3M797%N/AN/A
#3
$387.8M1026-2%N/AN/A
#4
$0.2M8-27%N/AN/A
#5
$3.1M19-10%N/AN/A
#6
$5.3M284%N/AN/A
#7
$2.6M16-48%N/AN/A
#8
$9.7M457%N/AN/A
#9
$8.4M398%N/AN/A
#10
$10.4M489%N/AN/A
Add Company

What Is Accucare Pediatric Nursing and Home Care?

Accucare Pediatric Nursing & Home Care has been family owned and operated since 1989. Accucare's founder, Ellen Foote RN, believes in a philosophy of living life to its fullest regardless of one’s disease or disposition. Accucare has become renowned for taking on the most critical and difficult pediatric cases. Our mission is to offer the highest quality patient-focused care that set standards and exceeds our patients' expectations. We are dedicated to providing care for the most challenging health issues; advocating to ensure that every child has the care that they need and deserve. Our belief is that the best place for a child to be is in their home. Follow Accucare Pediatric Nursing & Home Care https://www.facebook.com/accucarenursingandhomecare/ https://www.linkedin.com/company/accucarepediatricnursing/ https://twitter.com/AccucareC

keywords:N/A

N/A

Total Funding

52

Number of Employees

$12.6M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.2M54-8%N/A
#2
$16.2M5964%N/A
#3
$18M7412%N/A
#4
$25.4M771%N/A
#5
$32.8M1137%N/A